The fastest, most affordable biodegradability testing. Aropha’s streamlined approach to biodegradability testing combines AI-driven prediction and cutting-edge lab technologies to help teams screen, validate and certify materials in less time—cutting development cycles by 6+ months and saving up to 40% in testing costs. Get rapid access to the accurate biodegradability data needed to meet regulatory and eco-label requirements. High-throughput screening, predictive modeling and GLP-compliant testing are all available through a single, centralized Biodegradation Studio that’s designed to simplify and accelerate go-to-market timelines. Trusted by hundreds of companies globally, Aropha’s biodegradability testing model puts formulators in control with easier access to regulatory-ready data that’s faster, smarter and more cost-effective. Get tests started within 1-2 weeks.
Arima Genomics
Arima Genomics, Inc. is advancing human health and the life sciences by revealing actionable genomic insights. Researchers and clinicians use Arima Genomics’ innovative products and services to gain unparalleled access to the three-dimensional (3D) organization of the genome. This advanced technology enables exploration of disease mechanisms, the discovery of novel biomarkers and therapeutic targets, and identification of gene fusions to aid in patient management. To learn more, visit www.arimagenomics.com. | Arima Genomics, Inc. is advancing human genetics research by providing unparalleled insights into the three-dimensional (3D) organization of the genome. Researchers and clinicians use Arima Genomics’ innovative technologies to explore the structural and regulatory landscape of DNA, uncovering genetic mechanisms that drive health and disease. This advanced technology enables the discovery of novel biomarkers, therapeutic targets, and gene regulatory interactions, empowering breakthroughs in personalized medicine and genomic research.
ariadne.ai ag
ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics, transcriptomics and multi-omics data, including precise stitching, registration, segmentation and statistical analyses of cellular neighborhoods. SPATIAL works with any data type, whether you have fluorescence or histopathological staining, 2d or 3d data, or complex cell types such as neurons. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay. | ariadne.ai ag is a software CRO that solves biomedical image analysis challenges with custom-tailored solutions. We provide: 1) ready-made solutions for spatial biology and for the segmentation of 3d structures, 2) software engineering services leveraging artificial intelligence and classical image processing and 3) annotator teams. Our interdisciplinary team routinely turns terabytes of imaging data into quantitative, actionable results with fast turnaround times. We work with all common types of biomedical image data: high-throughput screening data, spatial biology, wide-field or fluorescent light microscopy, 2d and 3d electron microscopy, CT and MRI. | ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics and transcriptomics, including precise stitching, registration, segmentation and statistical analyses of cellular neighbourhoods. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay. Learn more by visiting https://ariadne.ai
Ardigen
Ardigen is your end-to-end trusted partner in the data-to-insights enablement journey that powers modern, AI-data-driven drug discovery. We help life science organizations transform fragmented, multimodal biomedical data into AI-ready foundations, actionable insights, and scalable discovery workflows. Our approach bridges the gap between data potential and discovery impact, grounded in a science-first model that starts with the biological question and aligns every step to measurable, real-world scientific outcomes. | Ardigen, a world-leading AI CRO, stands at the forefront of enabling AI transformation for the biotech and pharmaceutical sectors. Our objective is to increase the probability of success in the drug development process. We utilize our advanced platforms and deep expertise to turn vast amounts of data into pivotal, ready-to-use scientific insights. Leveraging our expertise, we also enhance the infrastructure that allows our clients to integrate and utilize these capabilities seamlessly within their organizations. | Ardigen is a leading AI Contract Research Organisation (CRO) dedicated to increasing the success rate of drug discovery. Recognized among the top 5% of AI in drug discovery companies worldwide, Ardigen integrates expertise in biology, bioinformatics, machine learning, and software engineering to deliver advanced computational solutions exclusively tailored for the biotechnology and pharmaceutical sectors. Over the past 10 years, we have earned the trust of over 120 clients, including 15 major pharmaceutical companies, by providing exceptional in silico research and data engineering services.
Aragen Life Sciences
Aragen Life Sciences is a globally renowned R&D and manufacturing solutions provider to the global life sciences industries. It offers a range of solutions across the drug discovery, development and manufacturing continue to advance small and large-molecule programs. The Company operates through a global network of six sites with a team of ~5000 employees and 450+ PhDs. Its expertise and experience have enabled over 400 customers to advance their research programs from early discovery through development and commercialization. Aragen’s innovative mindset, infrastructure, flexible business models, clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally. | Aragen Life Sciences is a leading R&D and manufacturing solutions provider for the life sciences industries worldwide. We offer end-to-end integrated or standalone solutions for small and large molecules. Established in 2001, we now operate from our network of sites located globally with a team of 3700+ scientists and 475+ PhDs. Our expertise and experience have enabled over 450+ customers in advancing their research programs from discovery through commercialization. Aragen’s innovative mindset, infrastructure, flexible business models have enabled us to serve large pharma or biotech, agrochemical, animal health and performance chemical industries globally. All our facilities conform to stringent regulatory standards. Our infrastructure has a built-up area of 1.2 million square feet, housing chemistry and biology labs, AAALAC-accredited animal houses, analytical labs, formulation development labs, kilo labs, pilot plants and manufacturing facilities. Aragen has been inspected by all the leading regulatory agencies of the world, including USFDA, WHO, PMDA, EDQM and EMEA. Aragen has submitted its letter of intent to the Science Based Targets initiative (SBTi) and is part of a growing list of organizations that are committed to setting emission reduction targets in line with the Paris Agreement to limit global warming. It is also a signatory to the GRI South Asia Charter on Sustainability Imperatives, a framework that helps to realize the 17 Sustainable Development Goals (SDGs) defined by the United Nation. We are proud to be a Great Place to Work® (GPTW) certified company for the third consecutive year in 2022. This recognition confirms our High-Trust, High-Performance Culture™ and places us among ‘companies with the best culture’ to work with. For more details, visit www.aragen.com | Aragen Life Sciences is a leading full-service CRDMO offering end-to-end solutions across the drug development lifecycle. With expertise spanning both small and large molecules, Aragen supports global biopharma and biotech companies in advancing molecules from early discovery through development to commercial manufacturing. Our integrated capabilities include discovery research, process development, formulation, analytical services, and scalable manufacturing. Full-service CRDMO powered by digital and AI, Aragen is committed to accelerating innovation and delivering high-quality, timely, and cost-effective solutions.
AQURA Labs
AQURA Labs is an independent cosmetic testing house specializing in structured in-vivo safety and clinical efficacy studies. We support brands with claim-driven study design, disciplined execution and decision-ready reporting built to protect timelines and strengthen launch strategy.
Applied Biological Materials Inc.
Founded in 2004, Applied Biological Materials (abm) Inc. is a pioneer in cell immortalization and expert in 3D and organoid cell culture. Based in Vancouver, Canada, our agility in developing and commercializing novel research tools and our complete portfolio of unique services have made us an invaluable partner to laboratories and research institutions around the world. Driven by a team of passionate and talented scientists, abm is dedicated to empowering the scientific community with the latest innovations for life sciences research and drug development.
ApconiX Ltd
ApconiX are experts in cardiac and CNS electrophysiology, target safety assessments and in all aspects of nonclinical toxicology and DMPK project support. ApconiX was formed with the objective to give companies of all sizes access to the breadth and depth of safety expertise generally only available in large pharma. Our lab team conduct hERG and CiPA cardiac screening assays and have developed an in vitro assay to better understand seizure liability (iSLA®). We continue to carry out research in other fields relevant to efficacy and safety in the CNS. The ApconiX Safety Science Team combines toxicology expertise and advanced data science, offering customized Acuity® target safety assessments (TSAs). The team also conducts modality or asset focused reports and will support you in understanding and optimizing project safety profiles. Our consultancy team provide a flexible nonclinical drug safety and DMPK support to your discovery and development team.
Antibody Design Labs
Antibody Design Labs (ADL) is a premier biotechnology company specializing in advanced antibody discovery and display technologies. As a global leader in phage-display reagents and a rising provider of yeast-display solutions, ADL serves as a strategic partner to therapeutic and diagnostic researchers. Our comprehensive portfolio includes the proprietary ALTHEA Gold™, Super Naive OPAL™, and MIM™ libraries for the discovery of antibodies, single-domain antibodies, and peptide binders. Beyond library screening, ADL offers end-to-end custom services—from library construction and screening to expression and characterization. Headquartered in San Diego, CA, ADL is dedicated to delivering innovative, high-quality solutions that accelerate the pace of biomedical discovery.
AntibodySystem
Aiming to develop the most reliable bioreagents, AntibodySystem was founded in 2019 in France by a team of professionals from top industrial companies and research institutes. The collective scientific and technical experiences in our team have brought breaking throughs in multiple product developments, including recombinant antibodies, recombinant proteins, biosimilar, RUO ELISA kits and other related products. By working with talented researchers and technicians, AntibodySystem continues to upgrade product qualities and lower the overall cost, offering accountable and affordable solutions for biolabs all over the world. Since its establishment, AntibodySystem has built long term and stable collaborations with academia, pharmaceutical industry, biotech companies and research hospitals, supporting their R&D by AntibodySystem’s bioreagents with excellent data accuracy and reproducibility.